Bharat Parenterals consolidated net profit rises 113.76% in the March 2022 quarter

Sales rise 28.78% to Rs 52.31 crore

Net profit of Bharat Parenterals rose 113.76% to Rs 4.04 crore in the quarter ended March 2022 as against Rs 1.89 crore during the previous quarter ended March 2021. Sales rose 28.78% to Rs 52.31 crore in the quarter ended March 2022 as against Rs 40.62 crore during the previous quarter ended March 2021.

For the full year,net profit rose 3.24% to Rs 21.05 crore in the year ended March 2022 as against Rs 20.39 crore during the previous year ended March 2021. Sales rose 3.60% to Rs 212.01 crore in the year ended March 2022 as against Rs 204.64 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales52.3140.62 29 212.01204.64 4 OPM %8.286.35 -13.0412.15 - PBDT6.284.09 54 34.5433.15 4 PBT4.722.40 97 27.8827.12 3 NP4.041.89 114 21.0520.39 3

Powered by Capital Market - Live News